Cargando…
OR13-005 – Investigation of clinical and laboratory significance of TNFRSF1A intron by reverse-phase protein microarray
Autores principales: | Drewe, E, Negm, O, Abduljabbar, W, Hawkins, P, Fairclough, L, Todd, I, Tighe, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952581/ http://dx.doi.org/10.1186/1546-0096-11-S1-A267 |
Ejemplares similares
-
The intracellular signalling pathway signature (the signalome) in PBMCs in the presence of a common TRAPS-associated genetic variant, TNFRSF1A p.(Arg121Gln) (legacy p.R92Q) is distinct from normal PBMCs and from other pathogenic variants
por: Bybee, A, et al.
Publicado: (2015) -
OR13-003 - TNFRSF11A molecular defects cause autoinflammatory disorders
por: Jéru, I, et al.
Publicado: (2013) -
PW02-019 - Inflammatory pathways activation in TRAPS patients
por: Negm, O, et al.
Publicado: (2013) -
P02-010 - A novel 24 nucleotide deletion in the TNFRSF1A
por: Rowczenio, DM, et al.
Publicado: (2013) -
Development and Validation of Protein Microarray Technology for Simultaneous Inflammatory Mediator Detection in Human Sera
por: Selvarajah, Senthooran, et al.
Publicado: (2014)